602
Participants
Start Date
September 30, 2002
Primary Completion Date
January 31, 2009
Study Completion Date
January 31, 2009
Zoledronic Acid
Participants received Zoledronate 4 mg IV 15-minute infusion every 6 months.
Letrozole
Participants received Letrozole 2.5 mg daily.
Hemoncare PC, Brooklyn
University of Pittsburgh Cancer Institute/Magee Womens Hospital, Pittsburgh
Frederick Memorial Hospital Regional Cancer Therapy Center, Frederick
Northern Virginia Oncology Group, Fairfax
Virginia Physicians, Inc.- Oncology, Richmond
Charleston Hematology Oncology, Charleston
Robert R. Carroll, MD, PA, Gainesville
Space Coast Medical, Titusville
Oncology Hematology Group of South Florida, Miami
Cancer Research Network, Inc., Plantation
Ocala Oncology Center, Ocala
Bay Area Oncology, Tampa
FL Community Cancer Center, Brooksville
Pasco Pinellas Cancer Center, New Port Richey
The Sarah Cannon Cancer Center, Nashville
Kentuckiana Cancer Institute, Louisville
Nashat Y. Gabrail MD Inc., Canton
Oncology Partners Network, Cincinnati
Physician Associates, Inc., Cincinnati
Dayton Clinical Oncology Program, Dayton
Cook Research Department at Spectrum Health, Grand Rapids
Metro Minnesota CCOP, Saint Louis Park
Odyssey Research Services, Bismarck
Hematology-Oncology Centers of the Northern Rockies, PC, Billings
Elmhurst Memorial Hospital, Elhurst
Methodist Cancer Center, Omaha
Louisiana Oncology Associates, Lafayette
Highlands Oncology Group, Springdale
Center for Oncology Research & Tx. PA, Dallas
St. Joseph Regional Cancer Center, Bryan
Cancer Specialists of South Texas, Corpus Christi
New Mexico Oncology Hematology, Ltd., Albuquerque
Clinical Trials & Research Associates, Inc., Montebello
Pacific Shores Medical Group, Long Beach
East Valley Hematology & Oncology, Burbank
Wilshire Oncology Medical Group, LaVerne
Cancer and Blood Institute of the Desert, Rancho Mirage
Redwood Regional Medical Group, Santa Rosa
Swedish Cancer Institute, Seattle
Rockwood Clinic, PS, Spokane
Eastern Connecticut Hematology/Oncology Associates, Norwich
New England Hematology/Oncology Associates, Wellesley
Hematology-Oncology Associates of Northern NJ, Morristown
VA Medical Center, San Juan
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY